Onderneming Acurx Pharmaceuticals, Inc.
Aandelen
ACXP
US00510M1045
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,035 USD | +4,90% | -4,01% | -46,87% |
Vakgebied
Aantal werknemers: 4
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Shawah
FOU | Founder | 57 | 01-07-17 |
David Luci
FOU | Founder | 57 | 01-07-17 |
Chief Tech/Sci/R&D Officer | - | - | |
Lisa Wilson
IRC | Investor Relations Contact | - | - |
Mintz Levin
LAW | General Counsel | - | - |
Larry Mortin
PRN | Corporate Officer/Principal | - | - |
Xiang Yu
PRN | Corporate Officer/Principal | - | - |
Les Johnson
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert de Luccia
FOU | Founder | 78 | 01-07-17 |
Joseph Scodari
BRD | Director/Board Member | 71 | 24-06-21 |
Thomas Harrison
BRD | Director/Board Member | 76 | 24-06-21 |
David Luci
FOU | Founder | 57 | 01-07-17 |
Carl Sailer
BRD | Director/Board Member | 54 | 23-10-18 |
Jack Dean
BRD | Director/Board Member | 82 | 24-06-21 |
James Donohue
BRD | Director/Board Member | 54 | 24-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 823 102 | 13 418 479 ( 84,80 %) | 0 | 84,80 % |
Bedrijfsgegevens
Acurx Pharmaceuticals, Inc.
259 Liberty Avenue Staten Island
10305, New York
+917 533 1469
http://www.acurxpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,87% | 30,7 mln. | |
+24,29% | 46,71 mld. | |
+48,83% | 41,8 mld. | |
-0,92% | 41,52 mld. | |
-5,86% | 29,55 mld. | |
+11,05% | 25,78 mld. | |
-20,91% | 19,26 mld. | |
+2,90% | 12,14 mld. | |
-2,41% | 12,08 mld. | |
+30,26% | 11,98 mld. |
- Beurs
- Aandelen
- Koers ACXP
- Onderneming Acurx Pharmaceuticals, Inc.